相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia
Robert E. Gallagher et al.
BLOOD (2012)
The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling
Emma Lang et al.
BLOOD (2012)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
Novel agents in acute myeloid leukemia
Alexander Ungewickell et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study
Yoshikazu Ito et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Requirement of PML SUMO Interacting Motif for RNF4-or Arsenic Trioxide-Induced Degradation of Nuclear PML Isoforms
Mohamed Ali Maroui et al.
PLOS ONE (2012)
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
Lindsay M. LaFave et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment
Emi Goto et al.
BLOOD (2011)
Leukemic transformation by the APL fusion protein PRKAR1A-RARα critically depends on recruitment of RXRα
Jihui J. Qiu et al.
BLOOD (2010)
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
Yukiya Yamamoto et al.
BLOOD (2010)
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H. A. Martens et al.
CANCER CELL (2010)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Hugues de The et al.
NATURE REVIEWS CANCER (2010)
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation
Hanane Boukarabila et al.
GENES & DEVELOPMENT (2009)
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-banding
Manabu Kusakabe et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
Takeshi Kondo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia
Alberto Catalano et al.
BLOOD (2007)
PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
Kazunori Ohnishi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia
Raffaella Villa et al.
CANCER CELL (2007)
Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARα as a component of the N-CoR co-repressor complex to repress transcription in vivo
Akihide Atsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein
R Carbone et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia
T Sternsdorf et al.
CANCER CELL (2006)
The methyl-CpG binding protein MBD1 is required for PML-RARα function
R Villa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent
A Takeshita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: Updated outcomes of the phase II study and postremission therapies
K Shigeno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
A sumoylation site in PML/RARA is essential for leukemic transformation
J Zhu et al.
CANCER CELL (2005)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fusion protein of retinoic acid receptor α with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo
A Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Retinoic acid resistance in acute promyelocytic leukemia
RE Gallagher
LEUKEMIA (2002)
Targeted removal of PML-RARα protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia
YK Jing et al.
BLOOD (2002)
Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
K Ohnishi et al.
LEUKEMIA (2002)
Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyeloicytic leukemia:: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo
DC Zhou et al.
BLOOD (2002)
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
SL Soignet et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
V Lallemand-Breitenbach et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities
E Duprez et al.
LEUKEMIA (2000)
分享论文
